Why Canadian committee and Health Canada differ on Oxford-AstraZeneca vaccine
Dr. Isaac Bogoch, an infectious diseases physician and member of Ontario's COVID-19 immunization task force, explains why the National Advisory Committee on Immunization is not recommending the Oxford-AstraZeneca vaccine for people 65 and older, even though Health Canada has authorized its use for adults of all ages.
UP NEXT
UP NEXT
-
Canadian doctor criticized for downplaying airborne threat of COVID-19
cbc.ca
-
Bank of Canada optimistic about post-pandemic recovery
cbc.ca
-
Battle over B.C. lakes highlights issue of public access to Crown land
cbc.ca
-
The divisive fight over Vancouver Island’s old-growth trees
cbc.ca
-
Can Derek Chauvin’s conviction spark police reform?
cbc.ca
-
Calls for increased transparency around N.B. mystery brain disease
cbc.ca
-
Crackdown continues on Putin opponents
cbc.ca
-
Fatal police shooting of Black teenager renews anger over policing in U.S.
cbc.ca
-
Minneapolis police department faces federal investigation after Chauvin conviction
cbc.ca
-
B.C. health-care workers share heartache as hospitalizations increase
cbc.ca
-
Canada considers halting air travel from India over surging cases, variant
cbc.ca
-
Bank of Canada governor's forecast for the Canadian economy
cbc.ca
-
Guilty verdict in George Floyd's murder brought Black man to knees
cbc.ca
-
Vaccine access for people working front-line jobs
cbc.ca
-
Nursing vacancies still a problem in Manitoba, NDP says
cbc.ca
-
Mixed views on new N.S. border restrictions
cbc.ca